Daniel Woolson - 15 Mar 2025 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
VP, GM-Infusion Capital
Signature
By: Paula Darbyshire, Attorney-in-Fact For: Daniel Woolson
Issuer symbol
ICUI
Transactions as of
15 Mar 2025
Net transactions value
-$185,624
Form type
4
Filing time
17 Mar 2025, 20:04:30 UTC
Previous filing
10 Mar 2025
Next filing
25 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +2,923 +23% $0.000000 15,488 15 Mar 2025 Direct F1
transaction ICUI Common Stock Tax liability $185,624 -1,294 -8.4% $143.45 14,194 15 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Performance Shares Options Exercise $0 -2,923 -50% $0.000000 2,924 15 Mar 2025 Common Stock 2,923 $0.000000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Securities are Performance-based Restricted Stock Units (PRSU).
F2 There is neither a purchase price nor an exercise price for the PRSUs.
F3 These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.